Literature DB >> 2617709

Comparison of home and hospital care of advanced cancer patients.

V Ventafridda1, F De Conno, A Viganò, C Ripamonti, M Gallucci, A Gamba.   

Abstract

Treatment and care of terminal cancer patients are conducted in different ways, according to the cultural, social, political and economical situations of the countries which have progressively adopted and developed them. In Italy there are no specialized structures such as "hospices" or the "palliative care units" like in the Anglo-Saxon world: the care of terminal cancer patients is carried out either in a general hospital or at their own home. In Milan and elsewhere there are home care teams in which doctors, nurses, social workers and volunteers, all work in connection with hospital structures. In this way, patients can receive specialized care for physical, psychological and social problems at home too. To evaluate costs and effectiveness of this program, a comparison was made between the home care and the conventional treatment carried out in general hospitals. Two groups of thirty terminal cancer patients have been studied: the first group was composed of hospital patients in Desio and the second one included patients cared for by the home care service organized by the Floriani Foundation and the Italian League against Cancer (Milan Section). We evaluated intensity and duration of pain, hours of sleep and hours of standing, sitting and lying, presence of side-effects, performance status and therapies. Data were also collected on the quality of life (Spitzer QLI), social and economical needs of the patients, type and quality of care, degree of awareness of the diagnosis by the patient and the family. This data were collected by the nurse who looked after the patient. Care costs were also quantified. The comparison between the two groups significantly favours the home care group as shown by the performance status after 2 weeks of care, the "health scale" and the Total index of the Spitzer QLI and in general the greater satisfaction of the care received. Home care produces results equivalent to those achieved in hospitals as far as clinical parameters are concerned. An approximate quantification of the costs shows that an average cost for a day's home care was about Lit. 52,500 as compared with Lit. 360,000 for a day's hospitalization.

Entities:  

Mesh:

Year:  1989        PMID: 2617709     DOI: 10.1177/030089168907500622

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  6 in total

1.  Effectiveness of home care programmes for patients with incurable cancer on their quality of life and time spent in hospital: systematic review.

Authors:  F W Smeenk; J C van Haastregt; L P de Witte; H F Crebolder
Journal:  BMJ       Date:  1998-06-27

2.  [Well-being of patients receiving specialized palliative care at home or in hospital].

Authors:  M Jansky; G Lindena; F Nauck
Journal:  Schmerz       Date:  2012-02       Impact factor: 1.107

3.  The National Tumor Association Foundation (ANT): A 30 year old model of home palliative care.

Authors:  Marina Casadio; Guido Biasco; Amy Abernethy; Valeria Bonazzi; Raffaella Pannuti; Franco Pannuti
Journal:  BMC Palliat Care       Date:  2010-06-08       Impact factor: 3.234

4.  Zoledronic acid significantly improves pain scores and quality of life in breast cancer patients with bone metastases: a randomised, crossover study of community vs hospital bisphosphonate administration.

Authors:  A Wardley; N Davidson; P Barrett-Lee; A Hong; J Mansi; D Dodwell; R Murphy; T Mason; D Cameron
Journal:  Br J Cancer       Date:  2005-05-23       Impact factor: 7.640

5.  Chapter 5: Referral to specialists and models of care.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2013-01

6.  Evidence on the economic value of end-of-life and palliative care interventions: a narrative review of reviews.

Authors:  Xhyljeta Luta; Baptiste Ottino; Peter Hall; Joanna Bowden; Bee Wee; Joanne Droney; Julia Riley; Joachim Marti
Journal:  BMC Palliat Care       Date:  2021-06-23       Impact factor: 3.234

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.